Fundz

Lexeo Therapeutics raised $95.0 million in an oversubscribed equity financing led by Braidwell LP and Adage Capital Partners LP to fund advancement of ongoing clinical stage programs.

PUBLIC · LXEOMar 15, 2024

Amount Raised

$95 Million

Round Type

Venture

New York CityBiotechnologyHealth CareGeneticsTherapeutics

Investors

Woodline Partners LPOmega FundsLongitude CapitalLaurion Capital ManagementInvusNovo Holdings A/SEventide Asset ManagementSurveyor CapitalRA Capital ManagementAdage Capital Partners LPBraidwell LP

Description

Lexeo Therapeutics announced the closing of an oversubscribed equity financing of approximately $95.0 million, co-led by Braidwell LP and Adage Capital Partners LP. The financing also involved participation from new and existing investors including RA Capital Management, Surveyor Capital, Eventide Asset Management, Novo Holdings A/S, Invus, Laurion Capital Management, Longitude Capital, Omega Funds and Woodline Partners LP. The proceeds will be used to fund advancement of ongoing clinical stage programs, and for working capital and general corporate purposes.

Who else raised in Genetics and Therapeutics around the same time

Companies in the same sectors as Lexeo Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • VolitionRx raised $100K (Pre-Seed) on March 12, 2024.
  • Precision BioSciences raised $7.5M on February 12, 2024.
  • Cerevance raised $47M (Series B) on April 29, 2024.
  • Ajax Therapeutics, Inc. raised $95M on April 26, 2024.
  • neurocare raised $17M (Funding Round) on April 24, 2024.
  • Red Arrow Therapeutics raised $4.5M (Seed) on April 23, 2024.

Who to call at Lexeo Therapeutics, and when

A new round usually means Lexeo Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Lexeo Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Lexeo Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Lexeo Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Lexeo Therapeutics

Location

345 Park Avenue South

New York City, New York, United States

About

Lexeo Therapeutics is a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Lexeo Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Lexeo Therapeutics's next move

See what Strategic adds

Lexeo Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.